Company intelligence / Profile preview

Arigo Biolaboratories

Burlington, Ontario, Canada

Ownership: Private
Employees: ~37
Development stage: Other

Overview

Arigo Biolaboratories provides high-quality research antibodies, antibody panels/duos, and ELISA kits validated for precision and sensitivity. Their multiplex ELISA kits allow detection of up to eight cytokines simultaneously. Products have received recognition from CiteAb and are compared favorably in performance against other leading suppliers.

Therapeutic areas: ImmunologyMetabolic DisordersInfectious DiseasesOtherOncologyNeurology
Modalities: AntibodyAntibody-drug conjugate (where relevant in customer experiments)Recombinant proteinELISA Kit (Device, used for detection)Monoclonal antibody
Industry: Non-Drug Biotech

Partnerships

Clementia Biotech (India, authorized distributor)Sanbio BV (Benelux, distributor)Cambridge Bioscience (UK, distributor)

Beyond the preview

Go deeper on Arigo Biolaboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arigo Biolaboratories.

Explore the full profile